Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 8/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | TP53 | P04637 | 4/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13139413 | 0.87 | TSHR (0.65) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL11029337 | 0.84 | TSHR (0.56) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL33482 | 0.84 | TSHR (0.55) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL731717 | 0.84 | TSHR (0.73) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL10917679 | 0.81 | TSHR (0.52) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL15435511 | 0.80 | TSHR (0.35) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL93462 | 0.80 | TSHR (0.84) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL30604742 | 0.80 | TSHR (0.84) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL12547083 | 0.79 | TSHR (0.60) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL4343485 | 0.79 | TSHR (0.67) | TSHRALDH1A1TP53HIF1ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12098223-B2 | Living radical polymerization method using zinc phthalocyanine dye as near-infrared photocatalyst | SOOCHOW UNIVERSITY (CN) | 2024-09-24 | — | — | US | disclosed |
| US-20230027085-A1 | PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR PRODUCING CURED PRODUCT OF FLUORORESIN, FLUORORESIN, FLUORORESIN FILM, BANK AND DISPLAY ELEMENT | CENTRAL GLASS COMPANY, LIMITED (JP) | 2023-01-26 | — | — | US | disclosed |
| US-20220325008-A1 | LIVING RADICAL POLYMERIZATION METHOD USING ZINC PHTHALOCYANINE DYE AS NEAR-INFRARED PHOTOCATALYST | SOOCHOW UNIVERSITY (CN) | 2022-10-13 | — | — | US | disclosed |
| WO-2022021499-A1 | ACTIVE FREE RADICAL POLYMERIZATION METHOD WITH ZINC PHTHALOCYANINE DYE AS NEAR-INFRARED LIGHT CATALYST | 苏州大学 | 2022-02-03 | — | — | WO | disclosed |
| WO-2022021499-A1 | ACTIVE FREE RADICAL POLYMERIZATION METHOD WITH ZINC PHTHALOCYANINE DYE AS NEAR-INFRARED LIGHT CATALYST | 苏州大学 | 2022-02-03 | — | — | WO | disclosed |
| CN-111875736-B | Active free radical polymerization method using phthalocyanine zinc dye as near infrared light catalyst | 苏州大学 | 2021-05-04 | — | — | CN | disclosed |
| CN-111875736-A | Active free radical polymerization method using phthalocyanine zinc dye as near infrared light catalyst | 苏州大学 | 2020-11-03 | — | — | CN | disclosed |
| WO-2020110793-A1 | PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR PRODUCING CURED PRODUCT OF FLUORORESIN, FLUORORESIN, FLUORORESIN FILM, BANK AND DISPLAY ELEMENT | セントラル硝子株式会社 | 2020-06-04 | — | — | WO | disclosed |
| US-8999377-B2 | System for forming a biocompatible foam using polymerizable alpha(1-4)glucopyranose polymers and gas-producing component | SURMODICS, INC. (US) | 2015-04-07 | — | — | US | disclosed |
| EP-2084196-B1 | SHAPE MEMORY POLYMERS | UNIV ROCHESTER (US) | 2014-01-22 | — | — | EP | disclosed |
| US-20070065482-A1 | Articles including natural biodegradable polysaccharides and uses thereof | SURMODICS MD, LLC | 2007-03-22 | — | — | US | disclosed |
| US-20070065482-A1 | Articles including natural biodegradable polysaccharides and uses thereof | SURMODICS MD, LLC | 2007-03-22 | — | — | US | disclosed |
| US-20070065482-A1 | Articles including natural biodegradable polysaccharides and uses thereof | SURMODICS MD, LLC | 2007-03-22 | — | — | US | disclosed |
| US-20070065483-A1 | In vivo formed matrices including natural biodegradable polysaccharides and uses thereof | SURMODICS MD, LLC | 2007-03-22 | — | — | US | disclosed |
| US-20070065483-A1 | In vivo formed matrices including natural biodegradable polysaccharides and uses thereof | SURMODICS MD, LLC | 2007-03-22 | — | — | US | disclosed |
| US-20070065483-A1 | In vivo formed matrices including natural biodegradable polysaccharides and uses thereof | SURMODICS MD, LLC | 2007-03-22 | — | — | US | disclosed |
| US-20070065484-A1 | In situ occlusion using natural biodegradable polysaccharides | SURMODICS MD, LLC | 2007-03-22 | — | — | US | disclosed |
| EP-1755696-A1 | NATURAL BIODEGRADABLE POLYSACCHARIDE COATINGS FOR MEDICAL ARTICLES | SurModics, Inc. (US) | 2007-02-28 | — | — | EP | disclosed |
| WO-2005113034-A1 | NATURAL BIODEGRADABLE POLYSACCHARIDES COATINGS FOR MEDICAL ARTICLES | SURMODICS, INC. (US) | 2005-12-01 | — | — | WO | disclosed |
| US-20050255142-A1 | Coatings for medical articles including natural biodegradable polysaccharides | SURMODICS, INC. | 2005-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070065482-A1 | Articles including natural biodegradable polysaccharides and uses thereof | CD44, FUT6, FGF23 | TSHR 2597/4885ALDH1A1 1429/4885TP53 2988/4885 |
| US-20070065483-A1 | In vivo formed matrices including natural biodegradable polysaccharides and uses thereof | CD44, ADAMTS4, BMP2 | TSHR 3925/4885ALDH1A1 1574/4885TP53 2036/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.